57 related articles for article (PubMed ID: 7923212)
1. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.
Sato S; Nakamura Y; Tsuchiya E
Cancer Res; 1994 Nov; 54(21):5652-5. PubMed ID: 7923212
[TBL] [Abstract][Full Text] [Related]
2. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis.
Cheng C; Hong W; Li Y; Xiao X; McKay J; Han Y; Byun J; Peng B; Albanes D; Lam S; Tardon A; Chen C; Bojesen SE; Landi MT; Johansson M; Risch A; Bickeböller H; Wichmann HE; Christiani DC; Rennert G; Arnold S; Goodman G; Field JK; Davies MPA; Shete SS; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zhu M; Shen H; Zienolddiny S; Grankvist K; Johansson M; Cox A; Hong YC; Yuan JM; Lazarus P; Schabath MB; Aldrich MC; Brennan P; Li Y; Gorlova O; Gorlov I; Amos CI;
J Thorac Oncol; 2023 Aug; 18(8):1003-1016. PubMed ID: 37150255
[TBL] [Abstract][Full Text] [Related]
3. HSSG: Identification of Cancer Subtypes Based on Heterogeneity Score of A Single Gene.
Pang S; Wu W; Zhang Y; Wang S; Niu M; Zhang K; Yin W
Cells; 2022 Aug; 11(15):. PubMed ID: 35954300
[TBL] [Abstract][Full Text] [Related]
4. Familial risk for lung cancer.
Kanwal M; Ding XJ; Cao Y
Oncol Lett; 2017 Feb; 13(2):535-542. PubMed ID: 28356926
[TBL] [Abstract][Full Text] [Related]
5. CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects.
Shen ZT; Wu XH; Li B; Shen JS; Wang Z; Li J; Zhu XX
J Cell Mol Med; 2015 Sep; 19(9):2136-42. PubMed ID: 25945422
[TBL] [Abstract][Full Text] [Related]
6. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Song L; Peng L; Bu Z; Yan SX; Feng J; Zhu XL; Liao XB; Yu XL; Yan D
Mol Genet Genomics; 2015 Apr; 290(2):545-58. PubMed ID: 25336053
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of asbestos and cigarette smoke on the development of lung adenocarcinoma: different carcinogens may cause different genomic changes.
Inamura K; Ninomiya H; Nomura K; Tsuchiya E; Satoh Y; Okumura S; Nakagawa K; Takata A; Kohyama N; Ishikawa Y
Oncol Rep; 2014 Aug; 32(2):475-82. PubMed ID: 24926563
[TBL] [Abstract][Full Text] [Related]
8. GSTP1 Ile105Val polymorphism is associated with lung cancer risk among Asian population and smokers: an updated meta-analysis.
Xu CH; Wang Q; Zhan P; Qian Q; Yu LK
Mol Biol Rep; 2014 Jul; 41(7):4199-212. PubMed ID: 24566690
[TBL] [Abstract][Full Text] [Related]
9. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
[TBL] [Abstract][Full Text] [Related]
10. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
[TBL] [Abstract][Full Text] [Related]
11. XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis.
Zhan P; Wang Q; Qian Q; Yu LK
J Exp Clin Cancer Res; 2013 Jan; 32(1):1. PubMed ID: 23289442
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
Ji YN; Wang Q; Suo LJ
PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer.
Valles I; Pajares MJ; Segura V; Guruceaga E; Gomez-Roman J; Blanco D; Tamura A; Montuenga LM; Pio R
PLoS One; 2012; 7(8):e42086. PubMed ID: 22876301
[TBL] [Abstract][Full Text] [Related]
14. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.
Kravchenko J; Akushevich I; Abernethy AP; Lyerly HK
PLoS One; 2012; 7(5):e37430. PubMed ID: 22629394
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
[TBL] [Abstract][Full Text] [Related]
17. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.
Lee Y; Yang X; Huang Y; Fan H; Zhang Q; Wu Y; Li J; Hasina R; Cheng C; Lingen MW; Gerstein MB; Weichselbaum RR; Xing HR; Lussier YA
PLoS Comput Biol; 2010 Apr; 6(4):e1000730. PubMed ID: 20369013
[TBL] [Abstract][Full Text] [Related]
18. P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.
Dai S; Mao C; Jiang L; Wang G; Cheng H
Hum Genet; 2009 Jun; 125(5-6):633-8. PubMed ID: 19357867
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic transformation of human bronchial cells by lead chromate particles.
Xie H; Holmes AL; Wise SS; Huang S; Peng C; Wise JP
Am J Respir Cell Mol Biol; 2007 Nov; 37(5):544-52. PubMed ID: 17585109
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer.
Brena RM; Morrison C; Liyanarachchi S; Jarjoura D; Davuluri RV; Otterson GA; Reisman D; Glaros S; Rush LJ; Plass C
PLoS Med; 2007 Mar; 4(3):e108. PubMed ID: 17388669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
